-
Mechanisms of duodenal adenoma development in familial polyposis syndromes
Study
EGAS00001006561
-
NTNU Data Access Committee for “ProstOmics: spatial and bulk multi-omics of prostate cancer” datasets archived in Federated EGA Norway
Dac
EGAC50000000277
-
The University of Hong Kong Gastric Cancer Organoids RHO Signaling Study Data Access Committee
Dac
EGAC00001002705
-
Genomic validation of the revised Bethesda criteria in terms of pathogenesis and oncologic significance
Study
EGAS00001003959
-
Cancer Genomics, ICR, summary data
Dac
EGAC50000000050
-
DAC for "Cancer-associated fibroblasts promote drug resistance in ALK-driven lung adenocarcinoma cells by upregulating lipid biosynthesis"
Dac
EGAC50000000076
-
Machine learning to detect the SINEs of cancer
Study
EGAS00001007169
-
DAC for "Longitudinal copy number variation analysis from plasma DNA of head and neck cancer patients under re-radiotherapy"
Dac
EGAC50000000114
-
Dac for "Combined single-cell transcriptomics and T-cell receptor sequencing reveal heterogeneity of mycosis fungoides between and within patients and identify a CD4+ cytotoxic subtype"
Dac
EGAC50000000168
-
DAC Barretos Cancer Hospital
Dac
EGAC50000000013
-
Time series analysis of neoadjuvant chemotherapy and bevacizumab treated breast carcinomas reveals a systemic shift in genomic aberrations
Study
EGAS00001003287
-
EC IO Data Access Committee UMCG
Dac
EGAC50000000334
-
First in vivo investigation of the impact of PARP inhibition with rucaparib alone and in combination with atezolizumab: results of the phase Ib COUPLET clinical study in advanced gynecologic and triple-negative breast cancers
Study
EGAS00001006100
-
Amsterdam UMC Head and Neck Cancer Biology and Immunology
Dac
EGAC50000000350
-
Singapore Gastric Cancer Consortium Data Access Committee
Dac
EGAC00001002251
-
PD-L1 blockade immunotherapy rewires cancer-induced emergency myelopoiesis
Dac
EGAC00001003503
-
Cancer Biomarkers team at The ICR DAC
Dac
EGAC50000000200
-
DAC for a single-cell multi-omic atlas of nodal B-cell non-Hodgkin lymphomas
Dac
EGAC50000000226
-
Genomic Alterations and Transcriptional Phenotypes in Circulating Tumor DNA and Matched Metastatic Tumor
Study
phs003689
-
BPH Tissues for Cell Culture and Analysis - A Patient-Derived Xenograft Model Using Benign Prostatic Tissues
Study
phs003692
-
Patient-Derived Breast Cancer Organoid Study
Study
phs002722
-
Prostate Cancer Upgrading Reference Set
Study
phs003670
-
Whole Exome and RNA Sequencing of 22 Patient-Derived Xenografts from Estrogen Receptor-Positive Breast Cancers
Study
phs003324
-
NCI Cancer Model Development for the Human Cancer Model Initiative (HCMI)
Study
phs001486
-
Genomic Data Access Committee for Early and Late Onset Colorectal Cancer Study
Dac
EGAC50000000359
-
A Comprehensive Genomic Study of Pediatric Malignancy
Study
phs001928
-
University of Hull
Dac
EGAC50000000402
-
IMPRESS: Improved Methylation Profiling using Restriction Enzymes and smMIP Sequencing, Combined with New Biomarker Panel, Creating Multi-Cancer Detection Assay
Study
EGAS00001007559
-
Testicular large B-cell lymphoma is genetically similar to PCNSL and distinct from nodal DLBCL
Study
EGAS50000000521
-
KDM6A Loss Triggers an Epigenetic Switch that Disrupts Urothelial Identity and Drives Cell Proliferation in Bladder Cancer
Study
phs002801
-
CIDR: Molecular Pathological Epidemiology of Colorectal Cancer
Study
phs001905
-
Expression quantitative trait loci influence DNA damage-induced apoptosis in cancer
Dac
EGAC50000000430
-
Transplant Outcomes in Aplastic Anemia (TOAA): GWAS and Whole Exome Sequence Data
Study
phs001710
-
5' Single cell RNA sequencing of pre-treatment tissues from lung cancer patients receiving immunotherapy
Study
EGAS00001006188
-
CRC organoid RNA-seq data access committee
Dac
EGAC50000000406
-
The Melbourne Urological Research Alliance (MURAL) Collection of Patient-Derived Models of Prostate Cancer
Study
phs003369
-
Epigenomics of Prostate Cancer from Cell Free Plasma
Study
phs003482
-
Integrative Molecular Characterization of Breast Cancer
Study
phs002419
-
Personalized Breast Cancer Vaccines Based on Genome Sequencing
Study
phs002787
-
Division of Brain Tumor Translational Research, National Cancer Center Japan Data Access Committee
Dac
EGAC50000000366
-
MOSAIC Window - Bladder dataset
Dataset
EGAD50000000967
-
Genomic Alterations in Normal Breast Tissues Preceding Breast Cancer Diagnosis (GANPBC)
Study
phs003822
-
The Role of E2F4 in Controlling Resistance to Irinotecan (CPT-11) in Human Colon Cancer
Study
phs003560
-
De Novo Mutation Rates at the Single-Mutation Resolution in the Human Genome
Study
phs002391
-
Temporal Evolution Reveals Bifurcated Lineages in Aggressive Neuroendocrine Small Cell Prostate Cancer Trans-Differentiation
Study
phs003230
-
Massachusetts General Hospital Cancer Center DAC for high-throughput microfluidic enrichment from whole leukopak for CTC-based liquid biopsy
Dac
EGAC50000000423
-
Loss of SDHB promotes dysregulated iron homeostasis, oxidative stress and sensitivity to ascorbate
Study
EGAS00001005279
-
BRCA-deficiency/HRD in individuals with HBOC
Study
EGAS00001007258
-
Methylation-Based Immune Deconvolution in Prostate Cancer Patients Before and After Radical Prostatectomy
Study
phs003660
-
PCPT and SELECT Cohorts: Core Infrastructure Support for Cancer Research
Study
phs003382
-
Long-Read Sequencing to Identify Inherited Mutations Predisposing to Breast Cancer
Study
phs003638
-
Mayo Clinic - Fecal Microbiota and Adenomas
Study
phs001204
-
Somatic Mutations in Individual Skin Cells
Study
phs003683
-
Detroit Research on Cancer Survivors (ROCS) and Disparities and Cancer Epidemiology - Colorectal Cancer (DANCE)
Study
phs003116
-
Whole Exome Sequencing and RNA Sequencing of High Grade Serous Ovarian Cancer in Black and White Patients
Study
phs003632
-
Single-Cell Genomic Analysis of Gastrointestinal Cancer
Study
phs001818
-
A Platform Study of Combination Immunotherapy for the Neoadjuvant and Adjuvant Treatment of Patients with Surgically Resectable Adenocarcinoma of the Pancreas
Study
phs003002
-
Yale SPORE in Skin Cancer Project 2
Study
phs002289
-
Next-generation sequencing raw data from metastatic prostate cancer biopsies - observational study Vall d'Hebron Institute of Oncology (Ethics committee code PR-AG-5248)
Dac
EGAC50000000448
-
cfDNA whole-genome TAPS data for cancer detection DAC
Dac
EGAC50000000440
-
Uncovering Principles of Adaptive Regulation in Cancer Resistance Through Deep Evolutionary Profiling
Study
phs003851
-
Melanoma Genome Sequencing Project
Study
phs000452
-
Patient-derived xenograft models of head and neck cancers
Dac
EGAC50000000502
-
Brain Cancer Center Committee
Dac
EGAC50000000456
-
Genomic Landscape of Colorectal Cancer in a Multi-Ancestry Cohort
Study
phs003464
-
International Cancer Proteogenome Consortium (ICPC): Proteogenomics of Oral Squamous Cell Carcinoma in Taiwan
Study
phs002580
-
Childhood Cancer Data Initiative (CCDI): CCDI Pediatric In Vivo Testing Program - Leukemia
Study
phs003164
-
Count Me In (CMI): The Metastatic Breast Cancer (MBC) Project (CMI-MBCproject)
Study
phs001709
-
Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors
Study
phs003845
-
Childhood Cancer Data Initiative (CCDI): Pediatric In Vivo Testing Program - Neuroblastoma
Study
phs003163
-
Women's Health Initiative Clinical Trial and Observational Study - Imaging
Study
phs003824
-
Single-Cell ATAC and RNA Sequencing of Human Breast Cancer Reveals Salient Cancer-Specific Enhancers
Study
phs003253
-
Transcriptome-Wide Association Study (TWAS) to Identify Susceptibility Genes for Colorectal Cancer
Study
phs002813
-
TIGER-LC High-Throughput Sequencing
Study
phs001199
-
CALGB 40601: Randomized Phase III Trial of Paclitaxel Combined With Trastuzumab, Lapatinib, or Both As Neoadjuvant Treatment of HER2-Positive Primary Breast Cancer
Study
phs001570
-
A Clone's Genomic Stability as a Biomarker of Its DNA-Damage Resilience
Study
phs003762
-
Multi-Modal Single-Cell, Spatial, and Genomic Analyses of Human Non-Small Cell Lung Cancer Brain Metastases
Study
phs003865
-
Metabolic Biomarkers in Thoracic Cancers
Study
phs003880
-
National Cancer Institute Multi-Ancestry Genome-Wide Association Study of Kidney Cancer (NCI-3)
Study
phs003505
-
NRG-GY017: Atezolizumab before and/or with Chemoradiotherapy in Immune System Activation in Patients with Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer
Study
phs003833
-
HPV-associated Cancer Consortium Data Access Committee
Dac
EGAC50000000088
-
Spatial Transcriptomics of Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery
Study
phs003862
-
MP2PRT: Genomic and Molecular Characterization of Biomarkers Associated with Tumor Angiogenesis, DNA Repair, and Immunologic Tolerance using Samples from the NRG Oncology Phase 3 Randomized Trial, GOG-0240 (NCT00803062)
Study
phs002293
-
Precision Interception of Gastric Cancer Precursors Through Molecular and Cellular Risk Stratification
Study
phs003648
-
Germline Genetics of Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)
Study
phs002962
-
California Teachers Study (CTS): Whole Genome Sequences From Under-Represented Populations
Study
phs002918
-
Cancer-Restricted Cryptic Antigens Are Targets for T Cell Recognition
Study
phs003887
-
Understanding Determinants of Racial Disparities in Lung Cancer Incidence
Study
phs003789
-
Prediction of Resistance and Sensitivity to HER2 Targeted Therapy in the Neoadjuvant Setting
Study
phs003275
-
Pharmacokinetics and Pharmacogenomics of Ribociclib in Race-Based Cohorts (LEANORA)
Study
phs003770
-
Immune-Related Adverse Events after Immune Checkpoint Blockade-Based Therapy are Associated with Improved Survival in Advanced Sarcoma
Study
phs003284
-
Cancer Moonshot Biobank
Study
phs002192
-
DAC for "Establishment and characterization of circulating tumor cells-derived organoids from metastatic breast cancer patients."
Dac
EGAC50000000371
-
Yale Policy for head and neck cancer and HPV clinical trials
Dac
EGAC50000000403
-
CANCAP03 Data Access Committee
Dac
EGAC50000000508
-
DAC for "Copy number variations and fragmentation features in cell-free DNA predict response in advanced non-small cell lung cancer patients under anti-PD-(L)1 therapy"
Dac
EGAC50000000308
-
Proteogenomic Analysis of CALGB40601 (ALLIANCE) a Neoadjuvant Phase III HER2-Positive Breast Cancer Trial
Study
phs003576
-
DNA Methylation in Prostate Tumor and Paired Benign Tissue for African and European Ancestry Men
Study
phs003516
-
Atezolizumab Plus Personalized Neoantigen Vaccination in Patients with Urothelial Cancer: a Phase 1 Trial
Study
phs003922
-
Timing and trajectory of BCR-ABL1 driven chronic myeloid leukaemia
Dataset
EGAD00001015473